Clinical Trial Update: Phase 1b Study of PLX5622 in Rheumatoid Arthritis Patients Who Are Receiving Methotrexate [Phase 1]

View source ↗

Summary

A Phase 1b clinical trial evaluating PLX5622 in rheumatoid arthritis patients receiving methotrexate has completed, reporting the trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• PLX5622

Snippet

Sponsor: Plexxikon | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED